ATG-034

N/A

Report date: 2023/06/28 15:09:38

Base Information

Drug NameATG-034
Drug Alias NameATG-034
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLeukocyte immunoglobulin-like receptor subfamily B member 4 antagonists
TargetsLeukocyte immunoglobulin-like receptor subfamily B member 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Corporation (Shanghai) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Corporation (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A